Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_assertion type Assertion NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_head.
- NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_assertion description "[These data implicate PTP-MEG2 as a mediator of blood glucose homeostasis through antagonism of insulin signaling, and suggest that modulation of PTP-MEG2 activity may be an effective strategy in the treatment of type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_provenance.
- NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_assertion evidence source_evidence_literature NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_provenance.
- NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_assertion SIO_000772 16679294 NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_provenance.
- NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_assertion wasDerivedFrom befree-20150227 NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_provenance.
- NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_assertion wasGeneratedBy ECO_0000203 NP660273.RA1QfiC_xgEmL7_d4DOiVmQGKpKgvE16kU5lt1cy5VozE130_provenance.